Outlook Therapeutics, Inc. (OTLK)
NASDAQ·Healthcare·Biotechnology
$0.65
-1.69%
Mkt Cap $119.77M
Analyst Ratings
Buy
4
Hold
2
Sell
0
Price Target (4 analysts)
$2.80
Range $1.60 – $4.00
Implied Upside
+330.7%
Consensus $2.80 vs current $0.65
NASDAQ·Healthcare·Biotechnology
$0.65
-1.69%
Mkt Cap $119.77M
Buy
4
Hold
2
Sell
0
Price Target (4 analysts)
$2.80
Range $1.60 – $4.00
+330.7%
Consensus $2.80 vs current $0.65